Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature.
Sign Up to like & getrecommendations! Published in 2019 at "Diagnostic microbiology and infectious disease"
DOI: 10.1016/j.diagmicrobio.2019.06.008
Abstract: Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary… read more here.
Keywords: urinary tract; pathogens causing; treatment; multidrug resistant ... See more keywords
Intravenous fosfomycin for the treatment of multidrug-resistant pathogens: what is the evidence on dosing regimens?
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Anti-infective Therapy"
DOI: 10.1080/14787210.2019.1573669
Abstract: ABSTRACT Introduction: The intravenous (IV) formulation of fosfomycin has been re-introduced in clinical practice mainly to overcome treatment failures against multidrug-resistant (MDR) bacteria. Appropriate dosing schedules of the IV formulation have not yet been established.… read more here.
Keywords: treatment; dosing regimens; treatment multidrug; multidrug resistant ... See more keywords